During the symposium entitled “What lessons can be drawn from the Covid-19 pandemic for the follow-up of patients with chronic respiratory failure at home – the place of telehealth?“ organized by AGIR à dom as part of the JIVD/ERCA 2022 conference, Laurent Morin, Medical Affairs Director at PhysioAssist, presented the preliminary results of the Homecare Bronchiectasis trial (NCT04742270). The replay of this presentation is now available!
The aim of this trial was to assess the feasibility of implementing Simeox therapy at home using telecare in non-CF-Bronchiectasis patients, as well as to evaluate the adherence to the Simeox therapy and other criteria (among which quality of life, patient satisfaction, etc.) over a follow-up period of 3 months. This innovative-designed trial has been based on the Simeox remote setup experience we have developed and consolidated during the Covid-19 pandemic.
The full symposium can be viewed at AGIRàdom_full_symposium_jivd/erca2022